Breaking News Instant updates and real-time market news.

RTN

Raytheon

$181.30

1.05 (0.58%)

, FTV

Fortive

$65.57

0.84 (1.30%)

04:55
09/08/17
09/08
04:55
09/08/17
04:55

Vertical Research Partners to hold a conference

8th Annual Global Industrials Conference is being held in Westbrook, CT on September 6-8.

RTN

Raytheon

$181.30

1.05 (0.58%)

FTV

Fortive

$65.57

0.84 (1.30%)

CBI

CB&I

$14.00

0.47 (3.47%)

SPXC

SPX Corporation

$24.42

0.28 (1.16%)

RXN

Rexnord

$24.05

-0.13 (-0.54%)

DHR

Danaher

$85.10

1.08 (1.29%)

XYL

Xylem

$62.48

0.46 (0.74%)

  • 13

    Sep

  • 13

    Sep

RTN Raytheon
$181.30

1.05 (0.58%)

08/08/17
08/08/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Amazon.com (AMZN), Alphabet (GOOG, GOOGL), and Facebook (FB) were reinstated with a Buy at Mizuho, while eBay (EBAY) and Twitter (TWTR) were reinstated with an Underperform. 2. Broadridge (BR) initiated with a Neutral at DA Davidson. 3. Brighthouse Financial (BHF) initiated with an Overweight at Barclays. 4. Akcea Therapeutics (AKCA) WAS initiated with an Outperform at BMO Capital and Cowen, an Outperform at Wells Fargo, as well as a Buy at Stifel. 5. Lockheed Martin (LMT) and Raytheon (RTN) were initiated with an Overweight at Morgan Stanley, while Northrop Grumman (NOC) was initiated with an Equal Weight, and General Dynamics (GD) was initiated with an Underweight at the firm. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/10/17
BARD
08/10/17
NO CHANGE
Target $212
BARD
Outperform
Raytheon price target raised to $212 from $170 at Baird
Baird analyst Peter Arment raised his price target on Raytheon to $212 from $170 to reflect significant program wins both domestically and internationally for missile defense and missile systems that puts the company in position for favorable organic growth in 2018 and beyond. Arment reiterated his Outperform rating on Raytheon shares.
08/08/17
MSCO
08/08/17
INITIATION
Target $188
MSCO
Overweight
Raytheon initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Rajeev Lalwani initiated Raytheon with an Overweight and a $188 price target saying it has leading positions in high demand areas of missile defense and internationally, and optionality around an A-rated balance sheet.
09/06/17
STFL
09/06/17
NO CHANGE
STFL
Stifel says United Tech deal strategic, not a sign of M&A 'floodgates opening'
Stifel analyst Joseph DeNardi said one of the only risks he sees to defense stocks' multiples would be a shift in cash deployment strategy from a focus on dividends and buybacks to M&A. However, he views United Technologies' (UTX) planned acquisition of Rockwell Collins (COL) as strategic and largely focused on its desire to regain leverage against Boeing (BA) and Airbus (EADSY) and not indicative of the M&A "floodgates opening" in the defense sector. Other publicly traded companies in the defense space include BAE Systems (BAESY), General Dynamics (GD), Lockheed Martin (LMT), Northrop Grumman (NOC) and Raytheon (RTN).
FTV Fortive
$65.57

0.84 (1.30%)

03/29/17
RHCO
03/29/17
UPGRADE
RHCO
Buy
Fortive upgraded to Buy from Hold at SunTrust
05/02/17
MSCO
05/02/17
DOWNGRADE
MSCO
Equal Weight
Fortive downgraded to Equal Weight on valuation at Morgan Stanley
Morgan Stanley analyst Nigel Coe downgraded Fortive to Equal Weight from Overweight citing valuation and maintained a $65 price target.
05/01/17
FBCO
05/01/17
NO CHANGE
Target $69
FBCO
Outperform
Fortive price target raised to $69 from $62 at Credit Suisse
Credit Suisse analyst Julian Mitchell raised his price target for Fortive to $69 from $62 following Q1 earnings. The analyst sees capital deployment and the upcoming Analyst Day as two near-term catalysts. He reiterates an Outperform rating on the shares.
03/29/17
03/29/17
UPGRADE
Target $67

Buy
Fortive upgraded to Buy on potential accretive M&A at SunTrust
As previously reported, SunTrust upgraded Fortive to Buy from Hold and raised its price target to $67 from $56. Analyst Charles Brady does not believe the market is fully reflecting upside potential from M&A, which is likely over the next 24 months. The analyst slightly increased estimates to reflect future accretive M&A saying he has high confidence that the company will complete a few deals over the next couple of years.
CBI CB&I
$14.00

0.47 (3.47%)

08/16/17
AGIS
08/16/17
NO CHANGE
Target $77
AGIS
Buy
W.R. Grace could rally $10 on CB&I unit acquisition, says Aegis
Aegis analyst Chris Kapsch believes Grace (GRA) is likely to become bigger via acquisitions and that CB&I's (CBI) process technology licensing division is a potential target. CB&I is a highly motivated seller, looking to complete the divestiture by year end, Kapsch tells investors in a research note. He believes Grace may be willing to pay as much as $1.5B for the asset and his "rough math" suggests such a deal could be 55c-60c accretive in FY18. This sort of deal accretion could be worth as much as $10 per share for Grace's equity, Kapsch argues. He has a Buy rating on Grace with a $77 price target.
08/16/17
08/16/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Dick's Sporting (DKS) was downgraded to Neutral from Buy at Monness Crespi, Goldman Sachs, MKM Partners, Buckingham, Citi, and to Neutral from Positive at Susquehanna, while being downgraded to Hold from Buy at Deutsche Bank and to Sector Perform from Outperform at RBC Capital. 2. Teva (TEVA) downgraded to Neutral from Buy at Citi with analyst Liav Abraham saying Teva is "cheap, but not cheap enough." 3. Advance Auto Parts (AAP) downgraded to Neutral from Overweight at Atlantic Equities with analyst Sam Hudson citing limited near-term visibility. 4. SL Green Realty (SLG) and Kilroy Realty (KRC) were downgraded to Neutral from Buy at BofA/Merrill, while Gramercy Property Trust (GPT) was downgraded to Underperform from Neutral. 5. CB&I (CBI) downgraded to Hold from Buy at Jefferies with analyst Martin Englert saying he is concerned that cost overruns at the company's two LNG projects could reemerge, adding risk to 2017-2019 earnings. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/30/17
BOFA
08/30/17
NO CHANGE
Target $9.5
BOFA
Underperform
CB&I price target lowered to $9.50 from $11.50 at BofA/Merrill
BofA Merrill Lynch analyst Anna Kaminskaya lowered her price target on CB&I shares to $9.50 from $11.50, stating that she assumes the company will divest its Technology segment for its announced expectation of $2B, which she views at a conservative multiple due to the "forced sale" scenario the company is in. She has also lowered her forecast for profitability at its core E&C segment. Kaminskaya keeps an Underperform rating on CB&I shares.
08/16/17
JEFF
08/16/17
DOWNGRADE
Target $12
JEFF
Hold
CB&I downgraded to Hold from Buy at Jefferies
Jefferies analyst Martin Englert downgraded CB&I to Hold and cut his price target for the shares to $12 from $35. The analyst is concerned that cost overruns at the company's two LNG projects could reemerge, adding risk to 2017-2019 earnings.
SPXC SPX Corporation
$24.42

0.28 (1.16%)

11/28/16
UBSW
11/28/16
NO CHANGE
Target $29
UBSW
Buy
SPX Corporation price target raised to $29 from $23 at UBS
UBS analyst Damian Karas raised his price target on SPC Corporation to $29 from $23 following the sale of its European Power Gen business. The analyst sees the transaction as significant as it eliminates the losses from the Power business. Karas reiterated his Buy rating on SPX Corporation shares.
RXN Rexnord
$24.05

-0.13 (-0.54%)

11/08/16
BARD
11/08/16
UPGRADE
Target $21
BARD
Outperform
Rexnord upgraded to Outperform from Neutral at Baird
Baird analyst Mig Dobre upgraded Rexnord to Outperform from Neutral following management's presentation of its growth plans over the next 3-5 years while acknowledging difficult end-market conditions over the past three years. The analyst noted shares have lagged and with lowered expectations and valuation and a sound long-term strategy, he sees opportunity at current levels. Dobre has a $21 price target on Rexnord shares.
07/21/17
07/21/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Groupon (GRPN) reinstated with an Underperform at BofA/Merrill. 2. LSC Communications (LKSD) initiated with a Neutral at JPMorgan. 3. Cars.com (CARS) initiated with a Hold at Craig-Hallum. 4. Rexnord (RXN) initiated with a Buy at Janney Capital. 5. Duluth Holdings (DLTH) initiated with a Buy at DA Davidson. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/21/17
JANY
07/21/17
INITIATION
Target $27
JANY
Buy
Rexnord initiated with a Buy at Janney Capital
Janney Capital analyst Michael Gaugler started Rexnord with a Buy rating and $27 fair value estimate.
12/27/16
BARD
12/27/16
NO CHANGE
Target $23
BARD
Outperform
Rexnord relatively inexpensive industrial laggard idea for 2017, says Baird
Baird analyst Mig Dobre said investors should look at Rexnord as an investment idea for 2017, calling it a relatively inexpensive industrial laggard. The analyst believes guidance is achievable and potentially conservative and said its delivering should help the story. Dobre reiterated his Outperform rating and $23 price target on Rexnord shares.
DHR Danaher
$85.10

1.08 (1.29%)

07/13/17
WELS
07/13/17
INITIATION
WELS
Market Perform
Danaher initiated at Wells Fargo
As noted earlier, Wells Fargo analyst Tim Evans started coverage of Danaher with a $90 price target and a Market Perform rating. Evans says that the company's acquisition of Cepheid indicates that it is focusing on clinical diagnostics markets, and he is cautious about that space. Additionally, he believes that some are overestimating the company's potential for revenue acceleration, and he says that its recent deals have been expensive.
07/13/17
07/13/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. HP Inc. (HPQ), 3D Systems (DDD), and Stratasys (SSYS) were initiated with a Neutral at Susquehanna. 2. Danaher (DHR) initiated with a Market Perform at Wells Fargo. 3. E-Trade (ETFC) and TD Ameritrade (AMTD) were initiated with a Buy at Rosenblatt, while Charles Schwab (SCHW) was initiated with a Neutral. 4. C&J Energy Services (CJ) initiated with a Buy at Jefferies. 5. BIO-key (BKYI) initiated with a Buy at Maxim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/07/17
06/07/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. PepsiCo (PEP) and Coca-Cola (KO) were downgraded to Market Perform from Outperform at BMO Capital. 2. Rent-A-Center (RCII) downgraded to Sell from Hold at Loop Capital with analyst Anthony Chukumba saying the secular shift to "virtual" rent-to-own has impaired the value of the company's core U.S. business. 3. HD Supply (HDS) was downgraded to Neutral from Outperform at Baird and to Hold from Buy at Drexel Hamilton. 4. IMAX (IMAX) downgraded to Hold from Buy at Benchmark with analyst Mike Hickey saying he fears movie goers' enthusiasm for recliner installations has shifted share away from IMAX and he now worries that recent per screen average deterioration could "prove less than transitory." 5. Danaher (DHR) downgraded to Neutral from Buy at Janney Capital with analyst Paul Knight saying he sees the company having more work to do optimizing its portfolio. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/13/17
WELS
07/13/17
INITIATION
Target $90
WELS
Market Perform
Danaher initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Tim Evans started Danaher with a Market Perform rating and $90 price target.
XYL Xylem
$62.48

0.46 (0.74%)

09/05/17
09/05/17
NO CHANGE

RBC Capital identifies companies that could see positive catalysts from Harvey
RBC Capital analyst Deane Dray identifies Grainger (GWW), Wesco (WCC), Xylem (XYL), and HD Supply (HDS) as companies that could benefit from Hurricane Harvey. The analyst says that Grainger " tends to be heavily involved in the cleanup and rebuilding process," and saw a one percentage point daily sales lift from Hurricane Sandy. The analyst thinks that Wesco's sales could be boosted by 0.5 percentage points as utility customers and first responders buy more of its products. She says that "Xylem's dewatering pumps business is expected to play a major role in the recovery/reconstruction efforts in flooded areas." Dray reports that the business accounts for more than 15% of the company's sales. The analyst estimates that about 11% of Hd Supply's revenue is derived from Texas.
06/21/17
BMOC
06/21/17
INITIATION
BMOC
Outperform
Xylem initiated with an Outperform at BMO Capital
BMO Capital analyst R. Scott Garham started coverage of Xylem with a $60 price target and an Outperform rating. The analyst says that the company's long-term earnings growth will soon accelerate, driven by "better verticals, secular trends, its 35-40% replacement/recurring business, emerging market growth and new go-to-market plans." He thinks that the company's margins will increase, driven by cost cutting.
08/02/17
OPCO
08/02/17
NO CHANGE
Target $66
OPCO
Outperform
Xylem price target raised to $66 from $60 at Oppenheimer
Oppenheimer analyst Jim Giannakouros raised his price target for Xylem to $66 from $60 following Q2 results. The analyst believes the company remains well positioned for sustainable MSD core growth on strength in PU markets. He reiterates an Outperform rating on the shares.
05/15/17
LEHM
05/15/17
UPGRADE
Target $59
LEHM
Overweight
Xylem upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Scott Davis upgraded Xylem to Overweight saying the recent pullback in shares provide a buying opportunity. The analyst views the integration of the Sensus acquisition and a likely uptick in water infrastructure investment as catalysts. He raised his price target for the shares to $59 from $51.

TODAY'S FREE FLY STORIES

10:30
11/23/17
11/23
10:30
11/23/17
10:30
General news
FX Action: EUR-USD, USD-JPY and other major pairings are in sideways mode »

FX Action: EUR-USD,…

DE

Deere

$145.25

6.02 (4.32%)

09:53
11/23/17
11/23
09:53
11/23/17
09:53
Upgrade
Deutsche Bank gets off sidelines, upgrades Deere shares to Buy »

Deutsche Bank analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

08:55
11/23/17
11/23
08:55
11/23/17
08:55
General news
FX Update: USD-CAD vaulted upwards on weak Canadian data »

FX Update: USD-CAD…

08:30
11/23/17
11/23
08:30
11/23/17
08:30
General news
FX Action: The USD index (DXY) logged a one-month low »

FX Action: The USD index…

TSLA

Tesla

$312.60

-5.21 (-1.64%)

08:08
11/23/17
11/23
08:08
11/23/17
08:08
Hot Stocks
Tesla CEO highlights 'record time' on Australian ion battery »

Tesla CEO Elon Musk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

TSLA

Tesla

$312.60

-5.21 (-1.64%)

08:07
11/23/17
11/23
08:07
11/23/17
08:07
Hot Stocks
Tesla completes construction on largest lithium ion battery in Australia »

The South Australian…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

GSK

GlaxoSmithKline

$35.06

0.25 (0.72%)

, INVA

Innoviva

$13.42

0.01 (0.07%)

07:56
11/23/17
11/23
07:56
11/23/17
07:56
Hot Stocks
GSK, Innoviva submit data to FDA for expanded Trelegy Ellipta label »

GlaxoSmithKline (GSK) and…

GSK

GlaxoSmithKline

$35.06

0.25 (0.72%)

INVA

Innoviva

$13.42

0.01 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVM

Silvercorp Metals

$2.51

-0.07 (-2.71%)

07:52
11/23/17
11/23
07:52
11/23/17
07:52
Hot Stocks
Silvercorp Metals to buy back up to 5% of shares »

Silvercorp Metals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEL

Cellcom Israel

$10.00

-0.1 (-0.99%)

07:49
11/23/17
11/23
07:49
11/23/17
07:49
Hot Stocks
Cellcom Israel now second layer company according to Concentration Law »

Cellcom Israel announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GASS

StealthGas

$4.07

0.36 (9.70%)

07:06
11/23/17
11/23
07:06
11/23/17
07:06
Recommendations
StealthGas analyst commentary at Jefferies »

StealthGas trades at only…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRT

Copart

$41.01

4.31 (11.74%)

07:02
11/23/17
11/23
07:02
11/23/17
07:02
Recommendations
Copart analyst commentary at Jefferies »

Copart price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

DE

Deere

$145.25

6.02 (4.32%)

06:56
11/23/17
11/23
06:56
11/23/17
06:56
Upgrade
Deere rating change at Deutsche Bank »

Deere upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

DE

Deere

$145.25

6.02 (4.32%)

06:55
11/23/17
11/23
06:55
11/23/17
06:55
Recommendations
Deere analyst commentary at Wells Fargo »

Deere price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

06:40
11/23/17
11/23
06:40
11/23/17
06:40
General news
FX Update: The dollar has remained on a weakening track »

FX Update: The dollar has…

SECO

Seeco Holding

$8.34

0.14 (1.71%)

04:55
11/23/17
11/23
04:55
11/23/17
04:55
Conference/Events
Seeco Holding management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Nov

04:55
11/23/17
11/23
04:55
11/23/17
04:55
Conference/Events
Deutsche Bank to hold a conference »

Thailand SET Corporate…

04:55
11/23/17
11/23
04:55
11/23/17
04:55
Conference/Events
RBC Capital to hold field trip »

European Utilities Field…

BASFY

BASF

$27.39

-0.13 (-0.47%)

04:55
11/23/17
11/23
04:55
11/23/17
04:55
Conference/Events
BASF management to meet with Evercore ISI »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Nov

  • 24

    Nov

RBS

RBS

$7.30

-0.04 (-0.54%)

04:55
11/23/17
11/23
04:55
11/23/17
04:55
Conference/Events
RBS management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Nov

  • 24

    Nov

04:25
11/23/17
11/23
04:25
11/23/17
04:25
General news
FX Action: USD-CAD punched out a 10-day low »

FX Action: USD-CAD…

02:35
11/23/17
11/23
02:35
11/23/17
02:35
General news
FX Update: The dollar has remained on a downward path »

FX Update: The dollar…

L

Loews

$49.36

-0.02 (-0.04%)

, GE

General Electric

$18.15

0.32 (1.79%)

18:41
11/22/17
11/22
18:41
11/22/17
18:41
Hot Stocks
Loews CEO James Tisch buys 3M shares of General Electric »

In a regulatory filing,…

L

Loews

$49.36

-0.02 (-0.04%)

GE

General Electric

$18.15

0.32 (1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRFS

BRF S.A.

$12.77

-0.16 (-1.24%)

18:06
11/22/17
11/22
18:06
11/22/17
18:06
Hot Stocks
BRF S.A. names Jose Aurelio Drummond Jr. as CEO »

BRF S.A. hereby informs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SU

Suncor

$35.42

0.2 (0.57%)

18:02
11/22/17
11/22
18:02
11/22/17
18:02
Hot Stocks
Suncor closes sale of equity interest in East Tan Farm, redeems $750M in debt »

Suncor successfully…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SAP

SAP

$113.85

-1.44 (-1.25%)

17:53
11/22/17
11/22
17:53
11/22/17
17:53
Periodicals
SAP launches investigation of sales practices in Gulf region, Reuters reports »

SAP has launched a formal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.